The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the Novavax vaccine as a booster in Australians aged 18 and over where an mRNA vaccine is not suitable.<\/p>\n\n\n\n
Novavax is the first protein-based COVID-19 vaccine to be provisionally approved by the Therapeutic Goods Administration (TGA).<\/p>\n\n\n\n
It has been proven safe and effective in protecting against severe illness or death associated with COVID-19 infection, with clinical trial data showing a robust immune response providing around 90 per cent protection from infection.<\/p>\n\n\n\n
Protein vaccines use a non-infectious protein component of the virus manufactured in a laboratory. After vaccination, immune cells recognise the vaccine protein as foreign and launch an immune response against it.<\/p>\n\n\n\n
More than 25,000 Australians have received a first dose of the Novavax COVID-19 vaccine since it was approved for use last month, ensuring that Australia continues to be one of the most highly vaccinated countries in the world.<\/p>\n\n\n\n
Australia was one of the first countries in the world to commence a whole-of-population COVID-19 booster program. More than 11.6 million Australians have received a booster dose.<\/p>\n\n\n\n
Approximately 94.5 per cent of people in Australia have completed their primary course of vaccination.<\/p>\n\n\n\n
The Australian Government has secured 51 million doses of Novavax to compliment the vaccine rollout.<\/p>\n\n\n\n
The Therapeutic Goods Administration is currently considering an application for whole of population use of the Novavax COVID-19 vaccine as a booster following a two-dose course of either the Pfizer or Moderna mRNA vaccine or the AstraZeneca vaccine.<\/p>\n\n\n\n
The TGA and ATAGI continue to review emerging evidence on all COVID-19 Vaccines.<\/p>\n\n\n\n
All Australians who are currently eligible for their primary course of vaccination, or for their booster dose, and who have not yet acted are urged to make a booking as soon as possible to get vaccinated.<\/p>\n\n\n\n
Please use the COVID-19 Clinic Finder<\/a> and make your appointment.<\/p>\n","protected":false},"excerpt":{"rendered":" The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the Novavax vaccine as a booster in Australians aged 18 and over where an mRNA vaccine is not suitable. Novavax is the first protein-based COVID-19 vaccine to be provisionally approved by the Therapeutic Goods Administration (TGA). It has been proven safe and … Continue reading “ATAGI recommends Novavax for use as a COVID-19 booster”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-15242","post","type-post","status-publish","format-standard","hentry","category-aussie"],"_links":{"self":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/15242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=15242"}],"version-history":[{"count":1,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/15242\/revisions"}],"predecessor-version":[{"id":15243,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/15242\/revisions\/15243"}],"wp:attachment":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=15242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=15242"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=15242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}